Search results
Found 6785 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Oxford researchers awarded funding to unlock disease biology
Awards and Appointments General Research
10 June 2020
Oxford Structural Genomics Consortium (SGC) is a key member of a new EUbOPEN consortium which has been awarded funding from the Innovative Medicines Initiative to develop openly available chemical tools for understanding human biology.
CATALYST trial: Oxford leads part of major COVID-19 drugs trial
Clinical Trials Coronavirus COVID-19 General
10 June 2020
As part of the UK NIHR multi-arm, multi-stage CATALYST Trial, researchers at the University of Oxford will investigate whether administering the anti-inflammatory drug infliximab to patients with COVID-19 can prevent progression to respiratory failure or death.
Imaging platform gets grant to teach frontline staff how to recognise COVID-19
Coronavirus COVID-19 General Innovation
8 June 2020
A team of radiologists and radiographers at Oxford University Hospitals and University of Oxford's Department of Oncology has secured a grant to customise a teaching platform to educate frontline NHS staff to diagnose COVID-19 using chest X-rays and CT scans.
The neurobiology of social distance: why loneliness may be the biggest threat to survival
Coronavirus COVID-19 General Research
8 June 2020
Never before have we experienced social isolation on a massive scale as we have during the evolving COVID-19 pandemic.
New resources on talking to children about illness and death during the COVID-19 pandemic
Coronavirus COVID-19 General Research
5 June 2020
The news that children currenty face may seem almost unspeakable. But, together, we must find words, and ways, to give voice to their experience and prevent millions of children struggling with their fears and uncertainty alone.
No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19
Clinical Trials Coronavirus COVID-19 General Research
5 June 2020
A new statement has been released from the Chief Investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial on hydroxychloroquine.
Clinical trials on hydroxychloroquine/ chloroquine in COVID-19. Statement in response to damaging recent events
Clinical Trials Coronavirus COVID-19 General Research
5 June 2020
On 4 June 2020, after a week of increasing scientific concern and scrutiny, first The Lancet, then a little over an hour later the New England Journal of Medicine, retracted studies that were based on inaccessible data, provided by the Surgisphere corporation. The studies have been extremely damaging to chloroquine and hydroxychloroquine COVID-19 clinical trials around the globe. Here is MORU’s statement in response to these events.
Bodleian iSkills videos now available
5 June 2020
Bacteria perform mass suicide to defend their colony
General Research
5 June 2020
A new study from researchers at Oxford University’s Departments of Zoology and Biochemistry shows that warring bacteria will engage in suicidal attacks in vast numbers to take down competitors.
Oxford University’s COVID-19 vaccine: next steps towards broad and equitable global access
Clinical Trials Coronavirus COVID-19 General Research
5 June 2020
The University of Oxford in partnership with AstraZeneca has taken the next steps in its commitment to broad and equitable global access to Oxford’s COVID-19 vaccine, following landmark agreements with the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi the Vaccine Alliance, and the Serum Institute of India (SII).
Brazilian Health Regulatory Agency approves trial of Oxford COVID-19 Vaccine
Clinical Trials Coronavirus COVID-19 General Research
4 June 2020
On 2 June, the Brazilian Health Regulatory Agency (ANVISA) approved the inclusion of Brazil in the clinical trials conducted by Oxford University and supported by AstraZeneca, considering 2,000 volunteers to be tested in the country.
First patient recruited in key COVID-19 drug treatment trial
Clinical Trials Coronavirus COVID-19 General Research
4 June 2020
A clinical trial to test whether Azithromycin, a commonly used antibiotic, can treat the symptoms of COVID-19 in outpatients has recruited its first patient.